The Conference Board uses cookies to improve our website, enhance your experience, and deliver relevant messages and offers about our products. Detailed information on the use of cookies on this site is provided in our cookie policy. For more information on how The Conference Board collects and uses personal data, please visit our privacy policy. By continuing to use this Site or by clicking "OK", you consent to the use of cookies. 
Corporate Governance and Cross-Border Mergers

Facilitated by deregulation and the growing liberalization of markets worldwide, companies are increasingly making cross-border rather than domestic M&A deals. This report, based on interviews with senior executives from companies that have undergone cross-border M&A transactions, discusses the role of corporate governance before, during, and after a cross-border merger.

Topics covered:

  • corporate governance issues in formulating the M&A transaction
  • corporate governance issues as the transaction progresses
  • the role of shareholders in M&As

Features insights from representatives of:

AstraZeneca, Aventis, BP Amoco, Daimler Chrysler, DWS Investments, Georgeson Shareholder Communications, Goodyear, Hermes Pensions Management, MeritaNordbanken, Standard Life Investments, ThysssenKrupp, and TIAA-CREF

Pricing
Research Report
Members: Sign in to see your special price (it may be complimentary!)
Non-Members: $295.00